5 changes on 1 July impacting pharmacists

All the new initiatives, funding schemes and Pharmaceutical Benefits Scheme (PBS) listings that kicked into gear on 1 July 2023.

Pharmacy and medical termination of pregnancy

One in six Australian pharmacists are pro-life and oppose elective termination of pregnancy. But this does not diminish their responsibilities to patients. Marie enters your...

Cautionary advisory labels

Scenario A 70-year-old male patient is being discharged from hospital today and you note that swallowing difficulties are detailed in his case history. The dispensing...

Changes to S3 salbutamol scheduling

Amendments to the S3 listing for salbutamol released last week will ease dispensing restrictions, hopefully reducing patient frustration and stopping unacceptable abuse experienced by some pharmacists.

High concentration topical capsaicin for chronic neuropathic pain

Neuropathic pain is associated with disability, reduced quality of life and employment, and increased healthcare costs. The prevalence of neuropathic pain in the general...

SHINGRIX now available to millions of vulnerable patients

From 1 November 2023, millions of Australians at risk of severe complications from shingles can receive a Shingrix vaccine under the NIP.